Rac1/Pak1/p38/MMP-2 Axis Regulates Angiogenesis in Ovarian Cancer-Reference-Cited by-同舟云学术

Rac1/Pak1/p38/MMP-2 Axis Regulates Angiogenesis in Ovarian Cancer

Published:2015-01-16 Issue:9 Volume:21 Page:2127-2137
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Gonzalez-Villasana Vianey,Fuentes-Mattei Enrique,Ivan Cristina,Dalton Heather J.,Rodriguez-Aguayo Cristian,Fernandez-de Thomas Ricardo J.,Aslan Burcu,del C. Monroig Paloma,Velazquez-Torres Guermarie,Previs Rebecca A.,Pradeep Sunila,Kahraman Nermin,Wang Huamin,Kanlikilicer Pinar,Ozpolat Bulent,Calin George,Sood Anil K.,Lopez-Berestein Gabriel

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting RAC1 reactivates pyroptosis to reverse paclitaxel resistance in ovarian cancer by suppressing P21‐activated kinase 4;MedComm;2024-09

2. Reduced ovarian cholesterol and steroid biosynthesis along with increased inflammation are associated with high DEHP metabolite levels in human ovarian follicular fluids;Environment International;2024-09

3. Polymeric nanofiber leveraged co-delivery of anti-stromal PAK1 inhibitor and paclitaxel enhances therapeutic effects in stroma-rich 3D spheroid models;International Journal of Pharmaceutics;2024-05

4. The association and clinicopathological significance of Integrin alphavbeta6 and Rac1 expression in gastric carcinoma;Frontiers in Oncology;2024-01-24

5. Identifying patterns to uncover the importance of biological pathways on known drug repurposing scenarios;BMC Genomics;2024-01-09